story of the week
Patient-Reported Outcomes Following Enzalutamide or Placebo in Men With Nonmetastatic, Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Patient-Reported Outcomes Following Enzalutamide or Placebo in Men With Non-Metastatic, Castration-Resistant Prostate Cancer (PROSPER): A Multicentre, Randomised, Double-Blind, Phase 3 Trial
Lancet Oncol 2019 Feb 12;[EPub Ahead of Print], B Tombal, F Saad, D Penson, M Hussain, CN Sternberg, R Morlock, K Ramaswamy, C Ivanescu, G AttardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.